{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:38:56Z","timestamp":1760146736593},"reference-count":22,"publisher":"Japanese Society of Veterinary Science","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2007]]},"DOI":"10.1292\/jvms.69.925","type":"journal-article","created":{"date-parts":[[2007,10,9]],"date-time":"2007-10-09T05:51:55Z","timestamp":1191909115000},"page":"925-930","source":"Crossref","is-referenced-by-count":15,"title":["Comparison of Dendritic Cell-Mediated Immune Responses among Canine Malignant Cells"],"prefix":"10.1292","volume":"69","author":[{"given":"Kyoichi","family":"TAMURA","sequence":"first","affiliation":[{"name":"Department of Veterinary Clinical Pathology, Nippon Veterinary and Life Science University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyoshi","family":"ARAI","sequence":"additional","affiliation":[{"name":"Department of Veterinary Clinical Pathology, Nippon Veterinary and Life Science University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"UENO","sequence":"additional","affiliation":[{"name":"Department of Veterinary Clinical Pathology, Nippon Veterinary and Life Science University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chie","family":"SAITO","sequence":"additional","affiliation":[{"name":"Department of Veterinary Clinical Pathology, Nippon Veterinary and Life Science University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"YAGIHARA","sequence":"additional","affiliation":[{"name":"Department of Veterinary Clinical Pathology, Nippon Veterinary and Life Science University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayu","family":"ISOTANI","sequence":"additional","affiliation":[{"name":"Department of Veterinary Clinical Pathology, Nippon Veterinary and Life Science University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"ONO","sequence":"additional","affiliation":[{"name":"Department of Veterinary Clinical Pathobiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsukimi","family":"WASHIZU","sequence":"additional","affiliation":[{"name":"Department of Veterinary Clinical Pathology, Nippon Veterinary and Life Science University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"BONKOBARA","sequence":"additional","affiliation":[{"name":"Department of Veterinary Clinical Pathology, Nippon Veterinary and Life Science University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ackermann, B., Troger, A., Glouchkova, L., Korholz, D., Gobel, U. and Dilloo, D. 2004. Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis. Klin. Padiatr. 216: 176-182.","DOI":"10.1055\/s-2004-822631"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1292\/jvms.68.1343"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.18.1.767"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Banchereau, J., Ueno, H., Dhodapkar, M., Connolly, J., Finholt, J. P., Klechevsky, E., Blanck, J. P., Johnston, D. A., Palucka, A. K. and Fay, J. 2005. Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon. J. Immunother. 28: 505-516.","DOI":"10.1097\/01.cji.0000171292.79663.cb"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Berntsen, A., Geertsen, P. F. and Svane, I. M. 2006. Therapeutic dendritic cell vaccination of patients with renal cell carcinoma. Eur. Urol. 50: 34-43.","DOI":"10.1016\/j.eururo.2006.03.061"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cranmer, L. D., Trevor, K. T. and Hersh, E. M. 2004. Clinical applications of dendritic cell vaccination in the treatment of cancer. Cancer Immunol. Immunother. 53: 275-306.","DOI":"10.1007\/s00262-003-0432-5"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ferrara, A., Nonn, M., Sehr, P., Schreckenberger, C., Pawlita, M., Durst, M., Schneider, A. and Kaufmann, A. M. 2003. Dendritic cell-based tumor vaccine for cervical cancer II: results of a clinical pilot study in 15 individual patients. J. Cancer Res. Clin. Oncol. 129: 521-530.","DOI":"10.1007\/s00432-003-0463-5"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hsu, F. J., Benike, C., Fagnoni, F., Liles, T. M., Czerwinski, D., Taidi, B., Engleman, E. G. and Levy, R. 1996. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med. 2: 52-58.","DOI":"10.1038\/nm0196-52"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1292\/jvms.68.809"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Koido, S., Kashiwaba, M., Chen, D., Gendler, S., Kufe, D. and Gong, J. 2000. Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA. J. Immunol. 165: 5713-5719.","DOI":"10.4049\/jimmunol.165.10.5713"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Lesterhuis, W. J., de Vries, I. J., Adema, G. J. and Punt, C. J. 2004. Dendritic cell-based vaccines in cancer immunotherapy: an update on clinical and immunological results. Ann. Oncol. 15 (Suppl. 4): 145-151.","DOI":"10.1093\/annonc\/mdh919"},{"issue":"4","key":"12","first-page":"829","volume":"60","author":"LODGE P A","year":"2000","journal-title":"Cancer Res.","ISSN":"http:\/\/id.crossref.org\/issn\/0008-5472","issn-type":"print"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Maier, T., Tun-Kyi, A., Tassis, A., Jungius, K. P., Burg, G., Dummer, R. and Nestle, F. O. 2003. Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate-pulsed dendritic cells. Blood 102: 2338-2344.","DOI":"10.1182\/blood-2002-08-2455"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Marshall, J. 2003. Carcinoembryonic antigen-based vaccines. Semin. Oncol. 30 (Suppl. 8): 30-36.","DOI":"10.1016\/S0093-7754(03)00233-1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Midgley, R. and Kerr, D. 1999. Colorectal cancer. Lancet 353: 391-399.","DOI":"10.1016\/S0140-6736(98)07127-X"},{"key":"16","unstructured":"16. Millard, A. L., Ittelet, D., Schooneman, F. and Bernard, J. 2003. Dendritic cell KLH loading requirements for efficient CD4+ T-cell priming and help to peptide-specific cytotoxic T-cell response, in view of potential use in cancer vaccines. Vaccine 21: 869-876."},{"key":"17","unstructured":"17. Morse, M. A., Deng, Y., Coleman, D., Hull, S., Kitrell-Fisher, E., Nair, S., Schlom, J., Ryback, M. E. and Lyerly, H. K. 1999. A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen. Clin. Cancer Res. 5: 1331-1338."},{"issue":"5","key":"18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1292\/jvms.58.469","volume":"58","author":"NAKAICHI M","year":"1996","journal-title":"J. Vet. Med. Sci.","ISSN":"http:\/\/id.crossref.org\/issn\/0916-7250","issn-type":"print"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Slingluff, C. L. Jr., Petroni, G. R., Yamshchikov, G. V., Barnd, D. L., Eastham, S., Galavotti, H., Patterson, J. W., Deacon, D. H., Hibbitts, S., Teates, D., Neese, P. Y., Grosh, W. W., Chianese-Bullock, K. A., Woodson, E. M., Wiernasz, C. J., Merrill, P., Gibson, J., Ross, M. and Engelhard, V. H. 2003. Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells. J. Clin. Oncol. 21: 4016-4026.","DOI":"10.1200\/JCO.2003.10.005"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.9.1.271"},{"key":"21","unstructured":"21. Tamura, K., Yamada, M., Isotani, M., Arai, H., Yagihara, H., Ono, K., Washizu, T. and Bonkobara, M. 2007. Induction of dendritic cell-mediated immune responses against canine malignant melanoma cells. Vet. J. (in press; doi:10.1016\/j.tvjl.2006.11.005)."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Timmerman, J. M., Czerwinski, D. K., Davis, T. A., Hsu, F. J., Benike, C., Hao, Z. M., Taidi, B., Rajapaksa, R., Caspar, C. B., Okada, C. Y., van Beckhoven, A., Liles, T. M., Engleman, E. G. and Levy, R. 2002. Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients. Blood 99: 1517-1526.","DOI":"10.1182\/blood.V99.5.1517"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jvms\/69\/9\/69_9_925\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T02:01:30Z","timestamp":1617069690000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jvms\/69\/9\/69_9_925\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.69.925","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007]]}}}